SCHEMBL5819638

SCHEMBL5819638

COc1ccc(-c2nc(C3CCNCC3)sc2-c2ccnc(N[C@@H](C)c3ccccc3)n2)cc1

nearest known ligand 0.55

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 7/20 0.53
ACHE P22303 1/20 0.52
RAF1 P04049 2/20 0.50
MAPK9 P45984 2/20 0.50
EGFR P00533 1/20 0.50
ERBB2 P04626 1/20 0.50
SRC P12931 1/20 0.50
KDR P35968 1/20 0.50
MAPK8 P45983 1/20 0.50
MAPK13 O15264 1/20 0.48
MAPK12 P53778 1/20 0.48
MAPK11 Q15759 1/20 0.48
MAPK14 Q16539 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6218709 0.90 KCNH2 (0.65) KCNH2ACHERAF1MAPK9EGFR
SCHEMBL6218705 0.90 KCNH2 (0.65) KCNH2ACHERAF1MAPK9EGFR
SCHEMBL5818632 0.90 KCNH2 (0.65) KCNH2ACHERAF1MAPK9EGFR
SCHEMBL5818972 0.89 EGFR (0.64) KCNH2RAF1MAPK9EGFRERBB2
SCHEMBL5818421 0.85 MAPK13 (0.56) KCNH2ACHERAF1MAPK9MAPK13
SCHEMBL5813602 0.84 MAPK13 (0.57) KCNH2ACHERAF1MAPK9MAPK13
SCHEMBL5820631 0.84 MAPK13 (0.55) KCNH2ACHERAF1MAPK9MAPK13
SCHEMBL5817158 0.83 KCNH2 (0.58) KCNH2ACHE
SCHEMBL5820567 0.83 KCNH2 (0.50) KCNH2MAPK9MAPK8MAPK13MAPK12
SCHEMBL5819343 0.83 EGFR (0.49) RAF1MAPK9EGFRERBB2SRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006137658-A1 NEW SUBSTITUTED 1,3-THIAZOLE DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF HAVING IMMUNOSUPPRESSION AND INFLAMMATION INHIBITORY ACITIVITY, INTERMEDIATE COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, A PROCESS FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME DONGBU HITEK CO., LTD. (KR) 2006-12-28 WO claimed